Nu Skin Enterprises, Inc. (NYSE: NUS) is a Consumer Defensive company (Household & Personal Products) with a market capitalization of $184M. The Maz Rating grades it against the other companies in its sector.
Nu Skin Enterprises, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.78, Nu Skin Enterprises, Inc. trades at 0.1x sales and 0.3x book value, with an EV/EBITDA of 8.7. Over the last twelve months it generated about $1.3B of revenue and a net loss of $232M. It runs a gross margin of 67.8%, an operating margin of -1.9% and a net margin of -17.7%. It shows return on equity of -34.8%, return on invested capital of -2.9% and a free cash flow yield of -14.2%. On the balance sheet: a debt-to-equity ratio of 0.46 and a current ratio of 2.04. Over the past 52 weeks the share price ranged from $3.77 to $11.67, with a beta of 0.93.
Nu Skin Enterprises, Inc. pays a dividend yielding 6.27%. Its Maz Dividend Score is 2.21 out of 5, ranked against the other dividend payers in its sector (Safety 3.28, Growth 1.20, Yield 3.90, Consistency 1.77).
11 Wall Street analyst ratings cover the stock: 10 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Nu Skin Enterprises, Inc. (NUS) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 89.7% / 30% · (Cash+Inv) / Mkt Cap (36m) 73.4% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 89.7% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 73.4% / 33% · Receivables / Mkt Cap (36m) 22.6% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 89.7% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 73.4% / 33.33% · Receivables / Mkt Cap (24m) 22.6% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 18.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 16.0% / 33.33% · Receivables / Avg Assets (4Q) 3.70% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 18.7% / 33.33% · (Cash+ST Inv) / Total Assets 15.3% / 33.33% · (Cash+Recv) / Total Assets 20.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
It depends on the standard you follow. As of September 2026, Nu Skin Enterprises, Inc. (NUS) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
No. Nu Skin Enterprises, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m) and (Cash+Inv) / Mkt Cap (36m).
Nu Skin Enterprises, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.